Management of cystic fibrosis-related diabetes in children and adolescents.
O'Riordan
Stephen M P
SM
The Developmental Endocrinology Research Group, The Institute of Child Health, University College London, London, UK. s.oriordan@ich.ucl.ac.uk
Robinson
Paul D
PD
Donaghue
Kim C
KC
Moran
Antoinette
A
D000293:Adolescent; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications* / Q000235:genetics / Q000401:mortality / Q000628:therapy*; D003920:Diabetes Mellitus / Q000209:etiology* / Q000235:genetics / Q000401:mortality / Q000628:therapy*; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology / Q000235:genetics / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000235:genetics / Q000628:therapy; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D007328:Insulin / Q000172:deficiency; D008833:Microcirculation / Q000235:genetics / Q000502:physiology; D010179:Pancreas / Q000473:pathology; D011141:Polyuria / Q000209:etiology; D011379:Prognosis; D015996:Survival Rate
D007328:Insulin